Victims of war or car crashes might be less likely to die from internal bleeding, thanks to technology in the works by Cleveland scientists.
The innovation, known as plastic coated platelets, is state-of-the-art. Currently, patients who experienced extreme blood loss typically undergo surgery and receive donated platelets, which helps with clotting. Unfortunately, this action can cause clots in other parts of the body and even increase the risk of stroke.
Conversely, this new plastic coated platelet technology could cause the formation of a clot that stops the flow of blood from an internal wound.
How does it work exactly? These synthetic particles have an outer coating of polyethylene glycol (PEG), a thickening agent commonly used in consumer products. Following this, the scientists attach a peptide, or small piece of protein, that adheres to platelets and ultimately forms a white, powdery substance.
One particular benefit of this synthetic innovation is its shelf life of at least two weeks, which is nearly twice as long as natural platelets. Another perk: This synthetic version does not require refrigeration. What’s more, the powder form makes it easy for emergency medical personnel to transport and inject after adding water.
At the moment, these particles are being tested on trauma victims. It remains to be seen how this might affect trauma care in the future. But one thing’s for sure–plastic will continue to shape the future of science. We’re proud to be in part of an industry that positively affects so many lives!